Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
- Conditions
- Pulmonary Fibrosis
- Registration Number
- NCT05899556
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patient is at least 18 years of age
- Diagnosis of pulmonary fibrosis
- Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
- Enrolled in another research study
- Inability to provide written informed consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of pulmonary fibrosis patients who decide to participate in a clinical study 3 months Rate of patients who remain in an pulmonary fibrosis clinical study to completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States